Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Five Star Equities Issues New Research Reports on AEZS, OXBT, UNIS and ZHNE

T.AEZS, TENX

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.

AEterna Zentaris Inc. (NASDAQ: AEZS) shares dropped 33.96 percent to close at $1.05 a share Wednesday. The stock traded between $0.99 and $1.15 on volume 19.99 million shares traded. The company announced the pricing of its previously announced public offering of 13.1 million units at a price of $1.15 per unit. Shares of AEterna Zentaris have fallen approximately 56.0 percent year-to-date.

Get more information on AEterna Zentaris and free access to the in-depth equity report at:
www.FiveStarEquities.com/AEZS

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) shares spiked 10.40 percent to close at $5.84 a share Wednesday. The stock traded between $4.98 and $7.15 on volume of 6.72 million shares traded. The company recently announced the closing of the acquisition of certain assets of Phyxius Pharma related to levosimendan. Shares of Oxygen Biotherapeutics have fallen approximately 55.0 percent year-to-date.

Get more information on Oxygen Biotherapeutics and free access to the in-depth equity report at:
www.FiveStarEquities.com/OXBT

Unilife Corp. (NASDAQ: UNIS) shares soared 43.93 percent to close at $4.03 a share Wednesday. The stock traded between $3.37 and $4.24 on volume of 15.28 million shares traded. The company announced that it has signed a long-term commercial supply contract with Hikma Pharmaceuticals PLC. Shares of Unilife have gained approximately 90.0 percent year-to-date.

Get more information on Unilife and free access to the in-depth equity report at:
www.FiveStarEquities.com/UNIS

Zhone Technologies Inc. (NASDAQ: ZHNE) shares surged 43.29 percent to close at $5.66 a share Wednesday. The stock traded between $4.41 and $5.70 on volume 7.23 million shares traded. The company announced that it has received Joint Interoperability Certification from the Defense Information Systems Agency for its FiberLAN Solution.

Get more information on Zhone Technologies free access to the in-depth equity report at:
www.FiveStarEquities.com/ZHNE

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today